Skip to content
1 min left
0% read
Ontrac Solutions logo

Ontrac Solutions

Technology Company
Chicago, Illinois, USA
Founded 2010
6

We are aggressively arming companies with GenAI and Public Cloud technologies daily!

Share:

Ontrac Solutions

Ontrac Solutions helps organizations adopt emerging technologies to scale smarter.

We build GenAI platforms, predictive analytics solutions, and drive cloud adoption.

We're also a HubSpot partner, supporting landing page design, website development, CRM integration, workflows, and automation.

From infrastructure to marketing ops, we deliver strategy and execution that drives growth.

Frequently Asked Questions About Ontrac Solutions

Ontrac Solutions is a finance company. We are aggressively arming companies with GenAI and Public Cloud technologies daily!

Ontrac Solutions helps organizations adopt emerging technologies to scale smarter. We build GenAI platforms, predictive analytics solutions, and drive cloud adoption. We're also a HubSpot partner, supporting landing page design, website development, CRM integration, workflows, and automation.

From.

Ontrac Solutions has been operating since 2010. You can verify their legitimacy through their official website and social media presence.

Ontrac Solutions operates in the finance sector of the cryptocurrency industry. Compare Ontrac Solutions with other finance companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Ontrac Solutions, research their track record (operating since 2010), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Ontrac Solutions is based in Chicago, Illinois, USA, has been operating since 2010. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Ontrac Solutions is based in Chicago, Illinois, USA, North America.

Ontrac Solutions was founded in 2010. The company currently has 6 employees.

Ontrac Solutions Details

Ontrac Solutions Tags

More About Ontrac Solutions

Work Model Details
Employees work from physical offices.

Latest from Academy

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

The Blast ecosystem has been crypto's most misunderstood narrative of 2026. While the market fixated on a 98.3% drawdown from all-time highs, less-publicized on-chain data tells a counterintuitive story. Three major protocol upgrades shipped since January 2025, 10% TVL growth appeared week-on-week in April, and 279,520 holders remain HODLing their positions on a chain the world has given up on.

7m
 Why Tokenlon's Revenue Doesn't Match Its Token Price

Why Tokenlon's Revenue Doesn't Match Its Token Price

DEX aggregation is "solved" in DeFi, right? 1inch, Jupiter, Paraswap have you covered. Except the data paints a different picture. Tokenlon quietly processes over $120 million in weekly trading volume and a 99.71% order success rate, yet remains shockingly absent from discussion in industry forums and panels. Either the market is correct and Tokenlon's fundamentals are not what we perceive, or a highly-traveled protocol has been willfully ignored.

Mia Halland logoMia HallandApr 26, 2026
8m
Sixty-Five Million in BioDAOs, BIO at One Cent

Sixty-Five Million in BioDAOs, BIO at One Cent

Bio Protocol's CEO recently revealed that PeptAI designed a new ADHD peptide candidate in 24 hours for roughly $1,500 in initial lab validation. While crypto traders focus on memecoins, Bio Protocol has quietly built a scientific funding platform backed by Pfizer Ventures, Binance Labs, and Arthur Hayes' Maelstrom Fund. The bio price trades at $0.031, down 96.5% from its all-time high of $0.889, despite $65M in combined BioDAO research funding and active clinical trials.

8m